These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33139561)

  • 1. Evidence that coronavirus superspreading is fat-tailed.
    Wong F; Collins JJ
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29416-29418. PubMed ID: 33139561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superspreading in early transmissions of COVID-19 in Indonesia.
    Hasan A; Susanto H; Kasim MF; Nuraini N; Lestari B; Triany D; Widyastuti W
    Sci Rep; 2020 Dec; 10(1):22386. PubMed ID: 33372191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-parametric method for determining epidemiological reproduction numbers.
    Pijpers FP
    J Math Biol; 2021 Mar; 82(5):37. PubMed ID: 33721104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Superspreading Suggests Mitigation by Social Network Modulation.
    Nielsen BF; Simonsen L; Sneppen K
    Phys Rev Lett; 2021 Mar; 126(11):118301. PubMed ID: 33798363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superspreading of SARS-CoV-2 in the USA.
    Pozderac C; Skinner B
    PLoS One; 2021; 16(3):e0248808. PubMed ID: 33765004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parameter estimation from ICC curves.
    Lega J
    J Biol Dyn; 2021 Dec; 15(1):195-212. PubMed ID: 33827379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2.
    Kuylen EJ; Torneri A; Willem L; Libin PJK; Abrams S; Coletti P; Franco N; Verelst F; Beutels P; Liesenborgs J; Hens N
    PLoS Comput Biol; 2022 Aug; 18(8):e1009980. PubMed ID: 35994497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chopping the tail: How preventing superspreading can help to maintain COVID-19 control.
    Kain MP; Childs ML; Becker AD; Mordecai EA
    Epidemics; 2021 Mar; 34():100430. PubMed ID: 33360871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control.
    Sneppen K; Nielsen BF; Taylor RJ; Simonsen L
    Proc Natl Acad Sci U S A; 2021 Apr; 118(14):. PubMed ID: 33741734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of COVID-19 basic reproduction ratio in a large urban jail in the United States.
    Puglisi LB; Malloy GSP; Harvey TD; Brandeau ML; Wang EA
    Ann Epidemiol; 2021 Jan; 53():103-105. PubMed ID: 32919033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative Strategies for the Estimation of a Disease's Basic Reproduction Number: A Model-Agnostic Study.
    Páez GN; Cerón JF; Cortés S; Quiroz AJ; Zea JF; Franco C; Cruz É; Vargas G; Castañeda C
    Bull Math Biol; 2021 Jul; 83(8):89. PubMed ID: 34216281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superspreading quantified from bursty epidemic trajectories.
    Kirkegaard JB; Sneppen K
    Sci Rep; 2021 Dec; 11(1):24124. PubMed ID: 34916534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature.
    Wegehaupt O; Endo A; Vassall A
    BMC Public Health; 2023 May; 23(1):1003. PubMed ID: 37254143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inferencing superspreading potential using zero-truncated negative binomial model: exemplification with COVID-19.
    Zhao S; Shen M; Musa SS; Guo Z; Ran J; Peng Z; Zhao Y; Chong MKC; He D; Wang MH
    BMC Med Res Methodol; 2021 Feb; 21(1):30. PubMed ID: 33568100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinfection with SARS-CoV-2: Discrete SIR (Susceptible, Infected, Recovered) Modeling Using Empirical Infection Data.
    McMahon A; Robb NC
    JMIR Public Health Surveill; 2020 Nov; 6(4):e21168. PubMed ID: 33052872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the superspreading potentials of COVID-19 across contact settings.
    Zhao Y; Zhao S; Guo Z; Yuan Z; Ran J; Wu L; Yu L; Li H; Shi Y; He D
    BMC Infect Dis; 2022 Dec; 22(1):936. PubMed ID: 36510138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of SARS-CoV-2.
    Salzberger B; Buder F; Lampl B; Ehrenstein B; Hitzenbichler F; Holzmann T; Schmidt B; Hanses F
    Infection; 2021 Apr; 49(2):233-239. PubMed ID: 33034020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of mobility restriction in COVID-19 superspreading events using agent-based model.
    Lima LL; Atman APF
    PLoS One; 2021; 16(3):e0248708. PubMed ID: 33735290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential Data Assimilation of the Stochastic SEIR Epidemic Model for Regional COVID-19 Dynamics.
    Engbert R; Rabe MM; Kliegl R; Reich S
    Bull Math Biol; 2020 Dec; 83(1):1. PubMed ID: 33289877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of high-dose exposure in transmission hot zones as a driver of SARS-CoV-2 dynamics.
    Wodarz D; Komarova NL; Schang LM
    J R Soc Interface; 2021 Mar; 18(176):20200916. PubMed ID: 33784886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.